日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Qinggan Yipi capsule ameliorates hepatic fibrosis in rats by down-regulating the TGF-β1/Smad2/3 signaling pathway and improving gut microbiota imbalance

清肝益脾胶囊通过下调 TGF-β1/Smad2/3 信号通路及改善肠道菌群失衡改善大鼠肝纤维化

Wenjing Xue #, Haiqing Liu #, Ziheng Su #, Siqi Wang, Junping Cheng, Yunzhi Pan, Lurong Zhang

Lipid Microparticles Show Similar Efficacy With Lipid Nanoparticles in Delivering mRNA and Preventing Cancer

脂质微粒在传递 mRNA 和预防癌症方面表现出与脂质纳米颗粒相似的功效

Afang Ji #, Minghao Xu #, Yunzhi Pan #, Lu Diao, Lin Ma, Li Qian, Junping Cheng, Mi Liu

Across-cancer specific immune responses induced by nanovaccines or microvaccines to prevent different cancers and cancer metastasis

纳米疫苗或微疫苗诱导的跨癌种特异性免疫反应可预防不同癌症及癌症转移

Lu Diao ,Lin Ma ,Junping Cheng ,Yunzhi Pan ,Zuofu Peng ,Lianjun Zhang ,Minghao Xu ,Yupei Li ,Xuenong Zhang ,Honglv Jiang ,Guoqiang Xu ,Fenghua Meng ,Zhiyuan Zhong ,Mi Liu

A novel regulatory loop miR-101/ANXA2/EGR1 mediates malignant characteristics of liver cancer stem cells

新型调控环 miR-101/ANXA2/EGR1 介导肝癌干细胞恶性特性

Sai Ma, Junping Cheng, Haiyan Wang, Ningling Ding, Feng Zhou, Runing Ji, Li Zhu, Chuanwu Zhu, Yunzhi Pan

The Influence Mechanism of Abnormal Immunophilin FKBP52 on the Expression Levels of PR-A and PR-B in Endometriosis Based on Endometrial Stromal Cell Model in Vitro

基于子宫内膜基质细胞体外模型探讨免疫亲和素FKBP52异常对子宫内膜异位症PR-A、PR-B表达水平的影响机制

Liling Liu, Junping Cheng, Fu Wei, Lihong Pang, Zhifu Zhi, Wenmei Yang, Weihong Tan

Chitin Oligosaccharide Modulates Gut Microbiota and Attenuates High-Fat-Diet-Induced Metabolic Syndrome in Mice

几丁质寡糖调节肠道菌群并减轻高脂饮食诱导的小鼠代谢综合征

Zheng, Junping; Cheng, Gong; Li, Qiongyu; Jiao, Siming; Feng, Cui; Zhao, Xiaoming; Yin, Heng; Du, Yuguang; Liu, Hongtao

The selective BACE1 inhibitor VIa reduces amyloid-β production in cell and mouse models of Alzheimer's disease

选择性 BACE1 抑制剂 VIa 可减少阿尔茨海默病细胞和小鼠模型中的淀粉样蛋白 β 生成

Xiaorui Cheng, Yu Zhou, Wei Gu, Jie Wu, Aihua Nie, Junping Cheng, Jinwu Zhou, Wenxia Zhou, Yongxiang Zhang